Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Pharmacological treatments for personality disorders.

Paris J.

Int Rev Psychiatry. 2011 Jun;23(3):303-9. doi: 10.3109/09540261.2011.586993. Review.

PMID:
21923229
2.

Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.

Mercer D, Douglass AB, Links PS.

J Pers Disord. 2009 Apr;23(2):156-74. doi: 10.1521/pedi.2009.23.2.156. Review.

PMID:
19379093
3.

[Pharmacological treatment for patients with borderline personality disorder: practice and study results].

Schwerthöffer D, Bäuml J, Rentrop M.

Fortschr Neurol Psychiatr. 2013 Aug;81(8):437-43. doi: 10.1055/s-0033-1335385. Epub 2013 Aug 12. Review. German.

PMID:
23939557
4.

Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.

Kutcher SP, Blackwood DH.

Can J Psychiatry. 1989 May;34(4):347-53. Review.

PMID:
2567621
5.

Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?

Abraham PF, Calabrese JR.

J Affect Disord. 2008 Nov;111(1):21-30. doi: 10.1016/j.jad.2008.01.024. Epub 2008 Mar 4. Review.

PMID:
18304647
6.

Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose.

Bellino S, Rinaldi C, Bozzatello P, Bogetto F.

Curr Med Chem. 2011;18(22):3322-9. Review.

PMID:
21728970
7.

Epidemiology, risk factors, and psychopharmacological management of suicidal behavior in borderline personality disorder.

Kolla NJ, Eisenberg H, Links PS.

Arch Suicide Res. 2008;12(1):1-19. doi: 10.1080/13811110701542010. Review.

PMID:
18240030
8.

The interface between borderline personality disorder and bipolar spectrum disorders.

Paris J, Gunderson J, Weinberg I.

Compr Psychiatry. 2007 Mar-Apr;48(2):145-54. Epub 2007 Jan 2. Review.

PMID:
17292705
9.

Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials.

Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM.

Br J Psychiatry. 2010 Jan;196(1):4-12. doi: 10.1192/bjp.bp.108.062984. Review.

10.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders.

Herpertz SC, Zanarini M, Schulz CS, Siever L, Lieb K, Möller HJ; WFSBP Task Force on Personality Disorders; World Federation of Societies of Biological Psychiatry (WFSBP).

World J Biol Psychiatry. 2007;8(4):212-44. Review.

PMID:
17963189
11.

Pharmacotherapy in personality disorders.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2007 Jun;45(6):15-9. Review.

PMID:
17601155
12.

The relationship of borderline personality disorder to the affective disorders.

Kroll J, Ogata S.

Psychiatr Dev. 1987 Summer;5(2):105-28. Review.

PMID:
2888107
13.

Psychopharmacology of borderline personality disorder: a review.

Cowdry RW.

J Clin Psychiatry. 1987 Aug;48 Suppl:15-25. Review.

PMID:
2886493
14.

Psychopharmacologic approaches to borderline syndromes.

Ellison JM, Adler DA.

Compr Psychiatry. 1984 May-Jun;25(3):255-62. Review. No abstract available.

PMID:
6145542
15.

Drug treatment of the personality disorders.

Stein G.

Br J Psychiatry. 1992 Aug;161:167-84. Review.

PMID:
1355689
16.

State of the art in the pharmacologic treatment of borderline personality disorder.

Feurino L 3rd, Silk KR.

Curr Psychiatry Rep. 2011 Feb;13(1):69-75. doi: 10.1007/s11920-010-0168-9. Review.

PMID:
21140245
17.

[Pharmacotherapy in personality disorders].

Wedekind D, Bandelow B, Rüther E.

Fortschr Neurol Psychiatr. 2005 May;73(5):259-67. Review. German.

PMID:
15880304
18.
19.

Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.

Hamrin V, McDonnell MA, Moffett J, Durso S.

Minerva Pediatr. 2008 Feb;60(1):87-101. Review.

PMID:
18277368
20.

Supplemental Content

Support Center